M&A Deal Summary |
|
---|---|
Date | 2015-01-09 |
Target | Spectra Analysis Instruments |
Sector | Test/Measurement Equipment |
Buyer(s) | DANI Instruments |
Sellers(s) | NMT Capital |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
DANI Instruments S.p.A. is a developer and manufacturer of GC and GC/MS instrumentation.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Test/Measurement Equipment) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
State (Massachusetts) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2015) | 1 of 1 |
Category | Private Equity Firm |
---|---|
Size | Small |
Type | Sector Agnostic |
NMT Capital is a private equity firm focused on tech-oriented growth industries. Areas of interest include medical devices, diagnostics, biotechnology, specialty pharmaceutical, drug discovery tools, software, communications, information technology, and advanced materials. NMT Capital is based in Quincy, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 8 of 10 |
Sector (Test/Measurement Equipment) | 1 of 1 |
Type (Add-on Acquisition) | 7 of 9 |
State (Massachusetts) | 1 of 2 |
Country (United States) | 6 of 8 |
Year (2015) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-12-02 |
Mini-Lap Technologies
Dobbs Ferry, New York, United States Minilap is developing and marketing ultra minimally invasive surgical instruments with direct-through-skin capability, eliminating the need to close the puncture and leaving little or no residual scar. Mini-Lap Technologies is based in Dobbs Ferry, New York. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-03-24 |
Magellan Biosciences
Chelmsford, Massachusetts, United States Magellan Biosciences, Inc. is a developer and manufacturer of FDA-cleared products for the testing of blood to diagnose lead poisoning in children and adults. |
Sell | - |